Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPH3 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
mRNA | PHF13 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | SLC12A4 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
mRNA | RP11-321N4.5 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | MVP | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | ITPRIPL1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |